Background {#Sec1}
==========

Rheumatoid arthritis (RA) is a chronic, inflammatory, progressive autoimmune disease that causes pain, limited range of motion (ROM) of joints, and joints destruction \[[@CR1]\], and seriously impacts patients' psychological \[[@CR2]\] and physical \[[@CR3]\] well-being. The wrist was affected in 50% of patients with RA during the first 2 years after onset of the disease, increasing to more than 90% after 10 years \[[@CR4]\]. There was increasing evidence that reduced wrist ROM was associated with RA patients' functional disability \[[@CR1], [@CR5]\]. Furthermore, evaluation of wrist ROM was important in the therapeutic approach to patients with RA \[[@CR6]\], and increasing joints motion was a particular goal of the surgical treatments for rheumatic wrist joints \[[@CR5]\]. Therefore, it is important to examine which factors have influence on ROM, especially in the wrist.

Several studies have suggested that ROM was associated with age, gender \[[@CR7]\], disease duration \[[@CR8]\], pain \[[@CR9], [@CR10]\], disease activity \[[@CR10]\], medical therapy \[[@CR11], [@CR12]\], laboratory indexes \[[@CR13]\], and disability \[[@CR1], [@CR14]\]. It has been reported that RA patients had a higher prevalence of anxiety and depression compared with the general population \[[@CR2]\], and the disease exerted an unfavorable impact on the quality of life \[[@CR3]\]. Our group has reported that socioeconomic status (SES) was significantly associated with patients' anxiety/depression and quality of life in rheumatic diseases \[[@CR15], [@CR16]\], but exact figures about the associations among SES, anxiety/depression, quality of life, and wrist ROM in RA patients were scarce. To minimize activity limitations and maintain quality of life, it is important for health professionals to increase RA patients' ROM and provide effective treatments.

To date, Sharp score has assumed a paramount position in the evaluation of RA patients with joint damage in hand-wrist joints. Previous studies have reported that female \[[@CR17]\], age \[[@CR18], [@CR19]\], body mass index (BMI) \[[@CR20]--[@CR22]\], socioeconomic status (SES) \[[@CR23]\], disease duration \[[@CR20], [@CR24], [@CR25]\], disease activity \[[@CR26], [@CR27]\], comorbid conditions \[[@CR28], [@CR29]\], erythrocyte sedimentation rate (ESR) \[[@CR17]\], and rheumatoid factor (RF) \[[@CR24], [@CR30]--[@CR32]\] were associated with joint destruction. However, little is known about the associations between Sharp score and the wrist ROM. Only a study from the USA reported that the number of deformed joints, which was rated on each of 48 joints as normal or abnormal in terms of alignment and ROM, was highly correlated with the total Sharp score in RA patients \[[@CR33]\]. In the present study, the relationships between influence factors or outcomes values and Sharp score or ROM measurements for the wrists were analyzed.

Therefore, the aims of the present study were the following: (1) to explore a broad range of possible risk factors of wrist ROM in patients with RA; (2) to determine whether RA patients' ROM measurements reflect Sharp score for the wrists.

Methods {#Sec2}
=======

Study participants {#Sec3}
------------------

Patients who fulfilled the American College of Rheumatology (ACR) criteria (1987 or 2012) for RA were recruited from the Affiliated Hospital of Nantong University from January 2015 to April 2016. Of the RA patients who were consecutively invited to participate in a single-centered cross-sectional study, 102 (91.1% of the patients) took part and completed the relevant questionnaires. Patients were excluded based on either of the following: (1) they were less than 18 years old; (2) they did not complete the questionnaire; (3) they did not complete the measurements of ROM and Sharp score for the wrists. This cross-sectional study was approved by the Ethics Committee of the Affiliated Hospital of Nantong University, and a written informed consent was obtained from each RA patient.

Primary outcomes {#Sec4}
----------------

Active ROM was measured bilaterally in the wrist with a goniometer. The goniometer was applied superficially at the dorsum of each respective joint. The angle of wrist volar flexion, dorsal flexion, radial deviation, and ulnar deviation were measured relative to a position of zero degrees. Participants had to carry out the motion with their muscle strength to increase the angle and keep their joints in position. Measurements were carried out by two trained physiotherapists under the supervision of a rheumatologist. Two physiotherapists were trained with procedures among 30 healthy subjects before the trial. They were kept unaware of the measurement data of their counterpart. Measurement procedures were standardized prior to the study. The values used for analysis were the means of the right and left sides.

Independent variables {#Sec5}
---------------------

At baseline, sociodemographic and disease characteristic \[including gender, age (years), BMI (kg/m^2^), disease duration (years), education (years), employment status, income/person/month (Yuan), health insurance, and comorbid conditions\] were recorded.

One experienced rheumatologist (GZ) and two rheumatologists (XY and GG) scored joint damage at the same time. Radiographs of both wrists were scored using the van der Heijde-modified Sharp Score (HSS). The total score for the wrists ranged from 0 to 87, with the erosion score (E score) ranging from 0 to 35 and the joint space narrowing score (JSN score) ranging from 0 to 32. All were read by the examiners without the knowledge of the patient identity \[[@CR34]\].

As described previously \[[@CR35]\], hand grip and pinch strength were measured with a hydraulic hand grip and pinch dynamiter \[[@CR36]\]. Physical function was evaluated by the Health Assessment Questionnaire (HAQ) \[[@CR37]\]. The Hospital Anxiety and Depression Scale (HADS) was used to assess levels of anxiety and depression \[[@CR38]\]. Participants' health status was assessed using the Short Form 36 (SF-36) \[[@CR39], [@CR40]\]. Disease activity was estimated with the valid and reliable 28-joint Disease Activity Score (DAS28) \[[@CR41]--[@CR43]\]. Several serological markers, ESR, C-reactive protein (CRP), and RF measured at the time of diagnosis were examined \[[@CR44]\].

The personal medication information was gained by querying the electronic medical records combined with self-reports of patients, including the use of NSAIDs, DMARDs, corticosteroids, and biologics.

We have described questionnaire and measurement administration in detail previously \[[@CR35]\]. Briefly, written questionnaires were provided on paper, and all participants completed the questionnaires under a physician's supervision in a clinical setting.

Statistical analysis {#Sec6}
--------------------

The data were expressed as the mean ± SD for continuous variables and as frequencies (%) for categorical variables. Descriptive analyses were performed to investigate the participants' characteristics. The Spearman and Pearson correlations analysis were used to compare the influence factors and outcome measurements between Sharp score and the ROM measurements for the wrists.

Furthermore, variables shown to be significantly associated with the primary outcome in the Spearman and Pearson correlations analysis were included in the multivariable regression analysis to identify the independent factors of wrist ROM. Statistical significance was set at *P* \< 0.05 (two-sided). Standardized regression coefficients (*β*) and the *R*-squared (*R*^*2*^) were presented to show the relative importance of the independent variables when compared to each other, and the proportion of the variance in the wrist ROM accounted for by the factors in the multivariable regression model, respectively \[[@CR45]\]. Analyses were completed using SPSS version 20.0.

Results {#Sec7}
=======

Sample characteristics {#Sec8}
----------------------

Ten RA patients did not complete the questionnaires due to lack of interest, resulting in the enrollment of 102 RA patients in the current study. Table [1](#Tab1){ref-type="table"} presented the baseline participant characteristics included in our analysis. The mean ± SD age of the respondents was 55.0 ± 11.7 years, and 86.3% were female. The mean ± SD disease duration was 8.4 ± 8.7 years, and 93.1 and 35.3% had health insurance and comorbid condition, respectively. The participants tended to have lower income (\< 3000 Yuan; 87.2%) and lower than a high school level of education (71.6%). The mean ± SD pain and DAS28 scores of the participants were 43.1 ± 27.2 and 3.7 ± 1.5, respectively. The patients tended to use DMARDs (91.3%), and 78.4% were RF positive. The mean (range) wrist ROM scores, grip/pinch strength, Sharp score, the HAQ score, the HADS anxiety and depression scores, and the scores of SF-36 PCS and MCS were shown in Table [2](#Tab2){ref-type="table"}.Table 1Baseline characteristics of 102 patients with rheumatoid arthritisCharacteristic/factorValueGender, female, no. (%)88 (86.3)Age, mean ± SD years55.0 ± 11.7BMI, mean ± SD kg/m222.6 ± 3.3Disease duration, mean ± SD years8.4 ± 8.7Education, years, no. (%)  ≤ 9 years73 (71.6)  \> 9 years29 (28.4)Employment status, no. (%) Full-time work63 (61.8) Part-time work37 (36.2) Unemployed2 (2.0)Income/person/month, Yuan, no. (%)54 (52.9)  ≤ 1000 Yuan35 (34.3) 1000--3000 Yuan12 (11.8) 3000--5000 Yuan1 (1.0)  ≥ 5000 Yuan95 (93.1)Health insurance, yes, no. (%)36 (35.3)Comorbid condition, yes, no. (%)43.1 ± 27.2VAS pain (range 0--100), mean ± SD4.1 ± 6.028-TJC, mean ± SD54 (52.9)28-SJC, mean ± SD2.6 ± 3.8DAS28, mean ± SD3.7 ± 1.5NAIDS usage, yes, no. (%)42 (41.2)DMARDs usage, yes, no. (%)93 (91.2)Corticosteroids usage, yes, no. (%)43 (42.2)Biologics usage, yes, no. (%)4 (3.9)ESR, mean ± SD mm/h25.7 ± 24.9CRP, mean ± SD mg/L15.5 ± 24.5RF positivity, yes, no. (%)80 (78.4)*BMI* Body mass index, *VAS* Visual analog scale, *TJC* Tender joint count, *SJC* Swollen joint count, *DAS28* Disease activity score in 28 joints, *NSAID* Nonsteroidal anti-inflammatory drugs, *DMARD* Disease modifying anti-rheumatic drugs, *ESR* Erythrocyte sedimentation rate, *CRP* C-reactive protein, *RF* Rheumatoid factorTable 2Clinical characteristics of 102 patients with rheumatoid arthritisCharacteristic/factorValueRangeWrist volar flexion ǂ, mean ± SD degrees38.7 ± 18.70 to 80Wrist dorsal flexion ǂ, mean ± SD degrees35.2 ± 17.20 to 65Wrist ulnar deviation ǂ, mean ± SD degrees29.7 ± 14.00 to 63Wrist radial deviation ǂ, mean ± SD degrees13.1 ± 7.80 to 35Sharp score for the wrists, mean ± SD8.6 ± 6.50 to 52Grip strength ǂ, mean ± SD kg13.2 ± 8.60 to 40Pinch strength ǂ, mean ± SD kg3.3 ± 2.20 to 11HAQ score (range 0--3), mean ± SD0.4 ± 0.60 to 2.6HADS-anxiety score (range 0--21), mean ± SD9.3 ± 2.74 to 17HADS-depression score (range 0--21), mean ± SD8.9 ± 2.44 to 15PCS score (range 0--100), mean ± SD43.9 ± 22.92.5 to 92.8MCS score (range 0--100), mean ± SD53.0 ± 22.21 to 100ǂ Mean of right and left sides. *HAQ* Health assessment questionnaire, *HADS* Hospital anxiety and depression scale, *PCS* Physical components summary, *MCS* Mental components summary

Higher sharp score was significantly associated with reduced ROM for the wrists {#Sec9}
-------------------------------------------------------------------------------

As shown in Table [2](#Tab2){ref-type="table"}, the mean (range) ROM scores varied from 13.1 (0 to 35) to 38.7 (0 to 80) degrees in the wrist joint actions, which were much lower than the normal reference. This result was in accordance with previous findings \[[@CR1], [@CR5], [@CR14]\]. The correlation between the ROM scores of the wrist joint actions ranged from 0.44 to 0.67. This finding confirms the conclusion of Steultjens, et al.*..* that joint ROM cannot be regarded as a unidimensional physical characteristic of osteoarthritis (OA) patients \[[@CR46]\]. Furthermore, Orces CH, et al \[[@CR33]\] reported that the number of deformed joints was significantly associated with the total Sharp score. We also found that a higher Sharp score was highly correlated with a lower ROM in the wrist (Table [3](#Tab3){ref-type="table"}). Thus, this raised an interesting question of whether RA patients' ROM measurements might reflect Sharp score for the wrists.Table 3Correlation between the wrist ROM and Sharp score for the wrists (*N* = 102)VariableWrist volar flexion (degrees)Wrist dorsal flexion (degrees)Wrist ulnar deviation (degrees)Wrist radial deviation (degrees)*rPrPrPrP*Wrist volar flexion ǂ (degrees) Wrist dorsal flexion ǂ (degrees)0.67\*\*0.000 Wrist ulnar deviation ǂ (degrees)0.62\*\*0.0000.64\*\*0.000 Wrist radial deviation ǂ (degrees)0.47\*\*0.0000.44\*\*0.0000.48\*\*0.000 Sharp score for the wrists− 0.62\*\*0.000− 0.63\*\*0.000− 0.67\*\*0.000− 0.42\*\*0.000ǂ Mean of right and left sides. \**P* \< 0.05, \*\**P* \< 0.01

SES, disease activity, laboratory indexes and outcome measures were significantly associated with sharp score and ROM for the wrists {#Sec10}
------------------------------------------------------------------------------------------------------------------------------------

As indicated in Table [4](#Tab4){ref-type="table"}, both Sharp score and the ROM for the wrists were correlated to a similar degree with disease duration, employment status, income, comorbid conditions, grip/pinch strength, the HAQ score, the SF-36 PCS and MCS scores (Table [4](#Tab4){ref-type="table"}).Table 4Correlations among the wrist ROM, Sharp score for the wrists, and the variables used in this study (N = 102)VariableSharp score for the wristsWrist volar flexion ǂ (degrees)Wrist dorsal flexion ǂ (degrees)Wrist ulnar deviation ǂ (degrees)Wrist radial deviation ǂ (degrees)*rPrPrPrPrP*Gender0.150.1290.020.8580.030.7460.030.7750.180.065Age, years−0.080.451−0.170.096− 0.080.434− 0.040.659− 0.040.713BMI, kg/m2−0.060.561−0.030.794−0.120.233−0.080.454−0.080.404Disease duration, years0.47\*\*0.000−0.30\*\*0.002−0.46\*\*0.000−0.39\*\*0.000−0.130.200Education, years−0.070.5150.26\*\*0.0080.20\*0.0480.21\*0.0370.160.118Employment status−0.22\*0.0250.26\*0.0080.070.4580.25\*0.0120.040.660Income/person/month, Yuan−0.31\*\*0.0020.40\*\*0.0000.31\*\*0.0020.30\*\*0.0020.120.224Health insurance0.050.6240.120.2480.25\*0.0120.22\*0.0270.160.108Comorbid condition0.23\*0.021−0.180.078−0.27\*\*0.006−0.26\*\*0.007−0.120.215VAS pain0.31\*\*0.002−0.41\*\*0.000−0.40\*\*0.000−0.43\*\*0.000−0.34\*\*0.00128-TJC0.120.229−0.30\*\*0.003−0.30\*\*0.002−0.28\*\*0.005−0.20\*0.04328-SJC0.160.102−0.23\*0.021−0.25\*0.011−0.130.195−0.21\*0.038DAS280.27\*0.017−0.32\*\*0.001−0.30\*\*0.002−0.31\*\*0.002−0.39\*\*0.000NAIDS usage−0.020.866−0.050.634−0.040.7020.000.9760.050.627DMARDs usage0.000.9950.080.438−0.010.958−0.070.477−0.050.604Corticosteroids usage0.060.529−0.170.080−0.27\*\*0.007−0.110.258−0.060.547Biologics usage0.040.4560.080.4380.000.9490.050.5670.050.447ESR, mm/h0.140.161−0.21\*0.039−0.20\*0.041−0.24\*0.014−0.38\*\*0.000CPR, mg/L0.120.214- 0.24\*0.014−0.29\*\*0.003−0.27\*\*0.006−0.36\*\*0.000RF positivity0.140.155−0.050.619−0.080.448−0.140.163−0.28\*\*0.005Grip strength ǂ (kg)−0.39\*\*0.0000.40\*\*0.0000.37\*\*0.0000.47\*\*0.0000.37\*\*0.000Pinch strength ǂ (kg)−0.30\*\*0.0020.29\*\*0.0030.25\*0.0130.32\*\*0.0010.24\*0.017HAQ score0.35\*\*0.000−0.49\*\*0.000−0.49\*\*0.000−0.47\*\*0.000−0.41\*\*0.000HADS-anxiety score0.160.109−0.100.322−0.25\*0.012−0.060.555−0.24\*0.019HADS-depression score0.050.610−0.21\*0.040−0.20\*0.047−0.120.250−0.23\*0.020PCS score−0.25\*0.0110.41\*\*0.0000.38\*\*0.0000.31\*\*0.0020.29\*\*0.003MCS score−0.22\*0.0230.26\*\*0.0080.32\*\*0.0010.21\*0.0300.190.113ǂ Mean of right and left sides. *BMI* Body mass index, *VAS* Visual analog scale, *TJC* Tender joint count, *SJC* Swollen joint count, *DAS28* Disease activity score in 28 joints, *NSAID* Nonsteroidal anti-inflammatory drugs, *DMARD* Disease modifying antirheumatic drugs, *ESR* Erythrocyte sedimentation rate, *CRP* C-reactive protein, *RF* Rheumatoid factor, *HAQ* Health assessment, questionnaire, *HADS* Hospital anxiety and depression scale, *PCS* Physical components summary, *MCS* Mental components summary. \**P* \< 0.05, \*\**P* \< 0.01

SES and RA disease-specific factors were the potential risk factors of wrist ROM {#Sec11}
--------------------------------------------------------------------------------

We used stepwise linear regression analysis to investigate the potential risk factors of wrist ROM, as shown in Table [5](#Tab5){ref-type="table"}. Only the independent variables that were significantly associated with wrist ROM were entered into model. We found that SES and RA disease-specific factors were the important predictors of wrist ROM. In addition, we found that there were significant correlations between corticosteroids usage and lower wrist dorsal flexion, which was in contrast with a previous finding \[[@CR12]\]. It might be explained that the radiological and functional damage of the wrist is likely to be a direct by-product of the more severe disease features, while steroid usage is likely to be a consequence of the individual clinical profile with more persistent and/or high disease activity.Table 5Results of the multivariable analysis of the association between factors and the ROM scores of the different wrist joint actions (degrees) (*N* = 102)FactorWrist volar flexion ǂ (degrees)Wrist dorsal flexion ǂ (degrees)Wrist ulnar deviation ǂ (degrees)Wrist radial deviation ǂ (degrees)*B*(95% CI)*βPB*(95% CI)*βPB*(95% CI)*βPB*(95% CI)*βP*Education, years6.11 (1.04, 11.18)0.200.019Income/person/month, Yuan7.00 (2.75, 11.25)0.280.0014.10 (0.39, 7.82)Employment status5.30 (0.17, 10.42)0.170.0434.58 (0.83, 8.33)0.200.017Disease duration, years−0.46 (−0.82, −0.10)−0.210.012−0.76 (−1.08, − 0.45)−0.390.000−0.56 (− 0.82, − 0.29)−0.350.000VAS pain−0.23 (− 0.34, − 0.11)−0.330.000−0.18 (− 0.29, − 0.08)−0.290.001−0.17 (− 0.26, − 0.09)−0.330.000DAS28−2.02 (−2.97, −1.08)−0.390.000Corticosteroids usage−7.31(−12.79, − 1.84)−0.210.009*R* ^2^0.340.400.370.15ǂ Mean of right and left sides. *VAS* Visual analog scale, *DAS28* Disease activity score in 28 joints, *B* Regression coefficient, *95% CI* 95% confidence interval of *B*, *β* Standardized regression coefficient*, R*^*2*^ *R*-squared

Discussion {#Sec12}
==========

This study provided evidence that Chinese RA patients were characterized with reduced wrist ROM, higher Sharp score for the wrists, decreased grip/pinch strength, lower PCS and MCS scores, higher HAQ score, and HADS anxiety and depression scores, which was similar to previous studies from other countries \[[@CR1]--[@CR3], [@CR5], [@CR8], [@CR14]\]. SES, RA disease-specific factors, and drug treatments were significantly associated with wrist ROM. In addition, the ROM measurements might reflect Sharp score for the wrists with regard to the influence factors and negative outcomes. To our knowledge, this is the first study exploring the relationships among SES, disease activity, Sharp score, anxiety/depression, quality of life, and wrist ROM in RA patients.

Khadr Z et al. reported that reduced ROM was associated with old age and female gender in a population of elderly people \[[@CR7]\]. In contrast, our study reported that there were no relationships between old age, female gender and lower wrist ROM. One possible explanation for the different results is the existence of cultural diversity and the different participants included in the studies with either Chinese or Western cohorts. Previous studies reported that RA could result in a high economic burden on the individual and the society \[[@CR47]\]. Our group reported that SES was significantly associated with patients' anxiety/depression and quality of life in rheumatic diseases \[[@CR15], [@CR16]\]. It was well known that SES is a multifactor. Occupation \[[@CR48]--[@CR50]\], education, and income \[[@CR51]\] were frequently used as measures of SES. Whether SES is associated with ROM remains unknown. In the current study, we found that RA patients with lower education level, lower income, lower employment status, and without health insurance were prone to suffer from lower wrist ROM. Due to work-related income reduction, lower education level, and lack of health insurance, RA patients might have a lower adherence rate to medication, which could lead to higher disease activity, more severe joints damage, and loss of physical function \[[@CR33]\].

With regard to clinical factors, we found that longer disease duration was significantly associated with lower wrist ROM. This result was in line with the finding of Goodson A and co-workers \[[@CR8]\]. When RA progresses, the wrist is increasingly affected \[bone erosions and rigid\], which possibly lowers the ROM. Furthermore, the current study also revealed that patients with comorbid conditions tended to suffer from reduced wrist ROM, which showed that comorbidity was an important predictor of functional status in RA patients \[[@CR52]\]. Pain is a major symptom in RA and is the leading reason for patients seeking medical care \[[@CR53], [@CR54]\]. Our study demonstrated significant negative correlations among pain, disease activity, and lower wrist ROM, which were similar to previous study \[[@CR1]\]. This result may be attributed to the fact that painful movement and the swelling of soft tissues around the joints are additional important factors contributing to decreased joints mobility in RA. Additionally, we found that there were significant correlations between corticosteroids usage and lower wrist dorsal flexion, which was in contrast with a previous finding \[[@CR12]\], which might be explained by the likely dependence of the steroid usage on the more aggressive or refractory forms of RA where corticosteroids were more frequently used. Furthermore, we also found that ESR, CRP, and RF were associated with wrist ROM, which were in line with a previous study \[[@CR13]\]. This finding may be attributed to the fact that the higher levels of ESR and CRP, and positive RF result in higher inflammatory activity, causing pain and swelling of the joints.

Interestingly, we found that there were significant association between ROM and Sharp score for the wrists. This finding indicated that ROM measurements might reflect Sharp score for the wrists. However, no causal conclusion could be inferred because the study was cross-sectional in design. Additional clinical trials are required, and the present study just provided a first step towards more focused studies in the future.

To identify which variables were most significantly correlated with lower wrist ROM, a stepwise linear regression analysis was used. Only independent variables individually associated with the primary outcome with a *P*-value \< 0.05 were entered into a multivariable regression model. We found that SES, RA disease-specific factors, and drug treatments were significantly associated with wrist ROM, which indicated that SES and RA disease-specific factors were independent risk factors of lower wrist ROM. However, steroid usage is likely to be a consequence of the individual clinical profile with more persistent and/or high disease activity.

However, this study has some limitations. First, the sample size was relatively small and all participants were from a single hospital. Second, the intra- and inter-observer reliabilities of the ROM measurements were not tested. Therefore, it might lead to possible biases of the measurements. However, to minimize the bias, all measurements were taken by two trained physiotherapists under the supervision of a rheumatologist. Third, the inter-rater reliability of Sharp score also could not be tested. However, to ensure the accuracy of Sharp score for the wrists, three rheumatologists evaluated wrist joint damage according to the HSS at the same time, and all readers were blind to the results. In addition, the questionnaires used in this study were all self-reported, which might result in possible biases of the outcomes.

Conclusions {#Sec13}
===========

SES, RA disease-specific factors, and drug treatments were significantly associated with the wrist ROM in RA patients. Additionally, our study suggested that ROM measurements might reflect Sharp score for the wrists with regard to influence factors and outcome measurements. The results indicated that rheumatologists and nurses should be aware of the RA patients' wrist ROM measurements, especially those with low SES, long disease duration, severe pain, and high disease activity to develop strategies to improve RA patients' quality of life.
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